SCHEMBL20230741

SCHEMBL20230741

Brc1ccc2c(c1)C(c1ccccc1)(c1ccccc1)c1cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc1O2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.39
AHR P35869 2/20 0.38
MEN1 O00255 6/20 0.38
KMT2A Q03164 6/20 0.38
MAPT P10636 4/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 3/20 0.38
ADORA2A P29274 2/20 0.35
ADORA1 P30542 2/20 0.35
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
NTSR1 P30989 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
DGAT1 O75907 1/20 0.35
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21732566 0.88 MEN1 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21732488 0.86 MEN1 (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL20230743 0.85 NR1H4 (0.40) NR1H4AHRMEN1KMT2AMAPT
SCHEMBL20212020 0.84 AHR (0.52) AHRMEN1KMT2AMAPTLMNA
SCHEMBL21732749 0.84 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21732399 0.84 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL23028759 0.84 MEN1 (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21732559 0.84 MEN1 (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21732507 0.84 MEN1 (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21732763 0.83 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CCNT1 NR1H4 4822/4885AHR 3189/4885MEN1 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.